Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Linlang Guo"'
Autor:
Yang Wen, Xue Sun, Lingge Zeng, Shumei Liang, Deyu Li, Xiangtian Chen, Fanrui Zeng, Chao Zhang, Qiongyao Wang, Qinsong Zhong, Ling Deng, Linlang Guo
Publikováno v:
Advanced Science, Vol 11, Iss 38, Pp n/a-n/a (2024)
Abstract Small cell lung cancer (SCLC) is characterized by rapid development of chemoresistance and poor outcomes. Cyclin‐dependent kinase 4/6 inhibitors (CDK4/6is) are widely used in breast cancer and other cancer types. However, the molecular mec
Externí odkaz:
https://doaj.org/article/98628396adf645e4bd067c93c6042796
Autor:
Runliang Zheng, Xuenian Wang, Lianghui Zhu, Renao Yan, Jiawen Li, Yani Wei, Fenfen Zhang, Hong Du, Linlang Guo, Yonghong He, Huijuan Shi, Anjia Han
Publikováno v:
iScience, Vol 27, Iss 9, Pp 110645- (2024)
Summary: The metastatic cancer of cervical lymph nodes presents complex shapes and poses significant challenges for doctors in determining its origin. We established a deep learning framework to predict the status of lymph nodes in patients with cerv
Externí odkaz:
https://doaj.org/article/72d09fa06c44428e8d56ef526468e583
Autor:
Wei Li, Zhongliang Wang, Qing Su, Jie Chen, Qian Wu, Xue Sun, Shuhan Zhu, Xiaodie Li, Hao Wei, Jialin Zeng, Linlang Guo, Chao Zhang, Jian He
Publikováno v:
JACS Au, Vol 4, Iss 4, Pp 1345-1355 (2024)
Externí odkaz:
https://doaj.org/article/08dcf014cf3d4e3891bff2a63e6c0da6
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/8a4421e1a8974b9e89244fcbed07dee4
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract There is currently a lack of efficacious treatments for patients with chemo-resistant small-cell lung cancer (SCLC), leading to poor prognoses. We examined a chemo-resistant SCLC cell line using genome-wide CRISPR/Cas9 screening and identifi
Externí odkaz:
https://doaj.org/article/15f7c2e7be054ad59f33cd0f3c974dd1
Autor:
Weiming Mou, Lingxuan Zhu, Tao Yang, Anqi Lin, Qiong Lyu, Linlang Guo, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Colon adenocarcinoma (COAD) is one of the major varieties of malignant tumors threatening human health today. Immune checkpoint inhibitors (ICIs) have recently begun to emerge as an effective option for the treatment of COAD patie
Externí odkaz:
https://doaj.org/article/d96ae038a375463f8fea51c74c36e91d
Autor:
Anqi Lin, Ningning Zhou, Weiliang Zhu, Jiexia Zhang, Ting Wei, Linlang Guo, Peng Luo, Jian Zhang
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract The characterization of immunological and genomic differences in small-cell lung cancer (SCLC) between East Asian (EA) and Caucasian patients can reveal important clinical therapies for EA patients with SCLC. By sequencing and analyzing a mo
Externí odkaz:
https://doaj.org/article/a479861fe7c64f5daf01a52c0b10ae36
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/92d8fdfb60d04dccba0567936d7f3bb7
Autor:
Lianghui Zhu, Huijuan Shi, Huiting Wei, Chengjiang Wang, Shanshan Shi, Fenfen Zhang, Renao Yan, Yiqing Liu, Tingting He, Liyuan Wang, Junru Cheng, Hufei Duan, Hong Du, Fengjiao Meng, Wenli Zhao, Xia Gu, Linlang Guo, Yingpeng Ni, Yonghong He, Tian Guan, Anjia Han
Publikováno v:
EBioMedicine, Vol 87, Iss , Pp 104426- (2023)
Summary: Background: Determining the origin of bone metastatic cancer (OBMC) is of great significance to clinical therapeutics. It is challenging for pathologists to determine the OBMC with limited clinical information and bone biopsy. Methods: We de
Externí odkaz:
https://doaj.org/article/1bf1c4b62c054a35bfd9b3535a341908
Autor:
Qiong Lyu, Weiliang Zhu, Ting Wei, Weimin Ding, Manming Cao, Qiongyao Wang, Linlang Guo, Peng Luo, Jian Zhang
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7863-7876 (2021)
Abstract Background The majority of patients with small‐cell lung cancer (SCLC) show a good response in the early stages of treatment, but more than 90% of patients will develop drug resistance. Therefore, biomarkers are urgently needed to identify
Externí odkaz:
https://doaj.org/article/f6cf9ddb76a74f719ffcb00033813430